New eczema ointment shows promise in phase 3 trial
NCT ID NCT07185282
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 28 times
Summary
This study tested an ointment called MH004 in 375 people aged 12 and older with mild to moderate eczema (atopic dermatitis). The goal was to see if it safely clears or nearly clears skin within 4 to 8 weeks. Participants used the ointment or a placebo cream, and those who finished could join a longer safety follow-up lasting 44 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University People's Hospital
Beijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.